Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
deals
johnson & johnson
life sciences
medicaid
3
×
national blog main
national top stories
new york blog main
new york top stories
novartis
3
×
spinal muscular atrophy
3
×
bill cassidy
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
eli lilly
fda
gene therapy
indiana blog main
indiana top stories
mark warner
medicare
meiragtx
national
parkinson's disease
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sanofi
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
What
alzheimer’s
bio
gene
roundup
age
bigger
biggest
come
companies
congress
deal
democrats
different
divided
drug
elections
emerging
fail
fallout
gave
increases
j
johnson
latest
losses
meiragtx
midterm
morning
panel
past
pharmaceutical
plan
plenty
political
postpartum
prescription
price
prices
raise
search
Language
Current search:
medicaid
×
novartis
×
" spinal muscular atrophy "
×
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel